ES2117934A1 - Alkylazole tetrahydropyridines (or 4-hydroxypiperidines) - Google Patents

Alkylazole tetrahydropyridines (or 4-hydroxypiperidines)

Info

Publication number
ES2117934A1
ES2117934A1 ES09501511A ES9501511A ES2117934A1 ES 2117934 A1 ES2117934 A1 ES 2117934A1 ES 09501511 A ES09501511 A ES 09501511A ES 9501511 A ES9501511 A ES 9501511A ES 2117934 A1 ES2117934 A1 ES 2117934A1
Authority
ES
Spain
Prior art keywords
alkylazole
hydroxypiperidines
tetrahydropyridines
amnesia
convulsions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09501511A
Other languages
Spanish (es)
Other versions
ES2117934B1 (en
Inventor
Vidal Ramon Merce
Constansa Jordi Frigola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to ES9501511A priority Critical patent/ES2117934B1/en
Publication of ES2117934A1 publication Critical patent/ES2117934A1/en
Application granted granted Critical
Publication of ES2117934B1 publication Critical patent/ES2117934B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Alkylazole tetrahydropyridines (or 4-hydroxypiperidines). This invention relates to a compound of general formula (I), a process for obtaining it and its use as a drug with therapeutic activity in the treatment of anxiety, psychosis, epilepsy, convulsions, motor problems, amnesia, cerebrovascular diseases and senile dementia.
ES9501511A 1994-07-29 1995-07-27 TETRAHIDROPIRIDINAS (0 4-HIDROXIPIPERIDINAS) ALQUILAZOLES. Expired - Fee Related ES2117934B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9501511A ES2117934B1 (en) 1994-07-29 1995-07-27 TETRAHIDROPIRIDINAS (0 4-HIDROXIPIPERIDINAS) ALQUILAZOLES.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9409443 1994-07-29
ES9501511A ES2117934B1 (en) 1994-07-29 1995-07-27 TETRAHIDROPIRIDINAS (0 4-HIDROXIPIPERIDINAS) ALQUILAZOLES.

Publications (2)

Publication Number Publication Date
ES2117934A1 true ES2117934A1 (en) 1998-08-16
ES2117934B1 ES2117934B1 (en) 1999-04-01

Family

ID=26154850

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9501511A Expired - Fee Related ES2117934B1 (en) 1994-07-29 1995-07-27 TETRAHIDROPIRIDINAS (0 4-HIDROXIPIPERIDINAS) ALQUILAZOLES.

Country Status (1)

Country Link
ES (1) ES2117934B1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445701A1 (en) * 1990-03-05 1991-09-11 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Novel tetrahydropyridine derivatives
EP0497659A1 (en) * 1991-01-28 1992-08-05 Laboratorios Del Dr. Esteve, S.A. Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs
EP0497658A1 (en) * 1991-01-25 1992-08-05 Laboratorios Del Dr. Esteve, S.A. Use of (omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)1H-azole derivatives for the preparation of medicines for the treatment of troubles of the capability of knowing functions
WO1994013659A1 (en) * 1992-12-09 1994-06-23 H. Lundbeck A/S Fused benzo compounds
WO1995003298A1 (en) * 1993-07-19 1995-02-02 Fujisawa Pharmaceutical Co., Ltd. BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445701A1 (en) * 1990-03-05 1991-09-11 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Novel tetrahydropyridine derivatives
EP0497658A1 (en) * 1991-01-25 1992-08-05 Laboratorios Del Dr. Esteve, S.A. Use of (omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)1H-azole derivatives for the preparation of medicines for the treatment of troubles of the capability of knowing functions
EP0497659A1 (en) * 1991-01-28 1992-08-05 Laboratorios Del Dr. Esteve, S.A. Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs
WO1994013659A1 (en) * 1992-12-09 1994-06-23 H. Lundbeck A/S Fused benzo compounds
WO1995003298A1 (en) * 1993-07-19 1995-02-02 Fujisawa Pharmaceutical Co., Ltd. BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Pharmacology and Experimental Therapeutics, Vol. 148, n‘ 1, 1965, pßginas 54-65, R. RODRIGUEZ et al. "Pharmacology of a group of Phenylpiperazine Tetrazole Derivatives with adtenergic Blocking actions" *

Also Published As

Publication number Publication date
ES2117934B1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
ZA956314B (en) Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles
ATE455763T1 (en) PIPERIDINE AND RELATED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
HU905333D0 (en) Process for producing cyclic amino-acid derivatives
MXPA05002420A (en) Thiazole compounds for the treatment of neurodegenerative disorders.
DE69630772D1 (en) NEW POLYCYCLIC AMINOPYRIDINE AS ACETYLCHOLINESTERASE INHIBITOR, METHOD FOR THE PRODUCTION AND THE USE THEREOF
GB0223494D0 (en) Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
HK1055118A1 (en) Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
HUT37139A (en) Process for production of 3-piperidil- and 3-pirrolidinil-/1h/-derivatives and medical preparatives consisting of such compounds
PT1664061T (en) Process for the synthesis of morphinane compounds and intermediates thereof
ATE427928T1 (en) FLUOROBENSAMIDE FOR THE TREATMENT OF ALZHEIMER'S OR SENILE DEMENTIA
NZ234672A (en) N-(1,2,3,4-tetrahydro-9-acridinyl)amide and carbamate derivatives and pharmaceutical compositions
HK1034078A1 (en) Process for purification of a cephalosporin derivative
ES2117934A1 (en) Alkylazole tetrahydropyridines (or 4-hydroxypiperidines)
HUP9901713A3 (en) Process for the production of enantiomerically-pure azetidine-2-carboxylic acid
ES2098186A1 (en) Pharmaceutical compositions based on aminomethylindoles and their therapeutical application as neuroprotectors in parkinson and alzheimer diseases
TWI245756B (en) Improved process for the preparation of 1,3-substituted indenes
MXPA05007565A (en) Process for the preparation of aryl fused polycyclic lactams.
MX9703368A (en) Process for the preparation of 1-halo-3-trialkylsilanyl-benzene derivatives.
MY112472A (en) Production of nitrosamine-free silicone articles
HU9200645D0 (en) Glyceraldehyde-3-pentanide and method for producing it
IL146257A0 (en) Method of producing methoxyimido acetic amide
UA31157A (en) The method for treatment of opioid addiction
HK1012349A1 (en) Process for the production of aminoazobicycloalkanes from oximes

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980816

Kind code of ref document: A1

Effective date: 19980816

FD2A Announcement of lapse in spain

Effective date: 20180806